Clovis Oncology, Inc. short interest in 2020
In 2020, Clovis Oncology, Inc.'s disclosed short interest ran from 37.15% of shares outstanding on 15 Jan 2020 to 41.55% on 31 Dec 2020, a change of +4.40 percentage points. The year's high was 46.78% on 31 Jan 2020 and its low 29.15% on 30 Apr 2020, averaging 39.04% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.92 days on 30 Oct 2020. Full history: Clovis Oncology, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022
2020 in figures
- Start of year
- 37.15% (15 Jan 2020)
- End of year
- 41.55% (31 Dec 2020)
- Change
- +4.40 pp
- High
- 46.78% (31 Jan 2020)
- Low
- 29.15% (30 Apr 2020)
- Average
- 39.04%
- Highest days to cover
- 13.92 (30 Oct 2020)
- SEC filings marked
- 9
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 37.15% | 3.03 | results (8-K) |
| 31 Jan 2020 | 46.78% | 3.53 | |
| 14 Feb 2020 | 46.74% | 4.85 | |
| 28 Feb 2020 | 32.42% | 2.66 | results (8-K), 10-K filed |
| 13 Mar 2020 | 34.92% | 4.93 | |
| 31 Mar 2020 | 34.20% | 3.10 | |
| 15 Apr 2020 | 31.80% | 5.98 | |
| 30 Apr 2020 | 29.15% | 3.86 | |
| 15 May 2020 | 34.47% | 3.27 | results (8-K), 10-Q filed |
| 29 May 2020 | 35.42% | 2.54 | |
| 15 Jun 2020 | 33.89% | 5.86 | |
| 30 Jun 2020 | 39.33% | 6.81 | |
| 15 Jul 2020 | 42.46% | 10.37 | |
| 31 Jul 2020 | 38.45% | 10.42 | |
| 14 Aug 2020 | 40.94% | 7.83 | results (8-K), 10-Q filed |
| 31 Aug 2020 | 41.46% | 6.82 | |
| 15 Sep 2020 | 42.99% | 7.64 | |
| 30 Sep 2020 | 44.40% | 8.09 | |
| 15 Oct 2020 | 44.66% | 11.04 | |
| 30 Oct 2020 | 46.03% | 13.92 | |
| 13 Nov 2020 | 44.74% | 7.27 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 38.09% | 8.87 | |
| 15 Dec 2020 | 35.00% | 7.07 | |
| 31 Dec 2020 | 41.55% | 6.36 |
See also: Clovis Oncology, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.